Topics
View Supplement
Rebecca Hepp, Editor-in-Chief
Kara Rickford, MS, and Jay Chhablani, MD
Ruby Hollinger, BA; Viet Chau, MD; and Jayanth Sridhar, MD
November/December 2022 Insert
Sponsored by NIDEK
Editorially independent content supported by advertising from Genentech
Sponsored by Allergan
Supported by Ocular Therapeutix, Inc.
November/December 2022 Supplement
This activity is provided by PRIME Education.
This activity is supported by an unrestricted educational grant from Regeneron.
This activity is supported by an unrestricted educational grant from EyePoint Pharmaceuticals.
This activity is supported by an unrestricted educational grant from Genentech, a member of the Roche Group.
Editorially independent content supported with advertising by Iveric Bio
This activity is supported by an unrestricted educational grant from Bausch + Lomb.
Recent Supplements
Understanding Fast Progression in Geographic Atrophy
View Insert
Gaining Patients’ Buy-in With Geographic Atrophy Treatment: The Journey From Diagnosis to Long-term Adherence
Editorially Independent Content, Supported With Advertising From Astellas
Business Matters: When and How To Hire
Editorially independent content supported with advertising by EyePoint
One to Watch: Samir N. Patel, MD
Editorially independent supported by Abbvie and Regenxbio
Rising Stars in Retina: Prashant D. Tailor, MD
Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease
This activity is supported by an independent educational grant from EyePoint Pharmaceuticals.
View More
Eyetube Retina Series
EYETUBE RETINA MEETING COVERAGE
_1773249222.png?auto=compress,format&w=75)
